@article{4b239d388fac468fab4aa8901064d179,
title = "Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials",
keywords = "IOP, Taflotan (R), Xalatan (R), ocular surface disease, ocular symptoms and signs, patient-related outcome, preserved latanoprost, IOP, Taflotan (R), Xalatan (R), ocular surface disease, ocular symptoms and signs, patient-related outcome, preserved latanoprost",
author = "Hannu Uusitalo and Evgeniy Egorov and Kai Kaarniranta and Yuri Astakhov and Auli Ropo",
year = "2016",
doi = "10.2147/opth.s91402",
language = "English",
volume = "10",
pages = "445--454",
}